Invention Grant
US08722674B2 1,3,5-triazine-2,4,6-triamine compound or pharmaceutical acceptable salt thereof, and pharmaceutical composition comprising the same
有权
1,3,5-三嗪-2,4,6-三胺化合物或其药学上可接受的盐，以及包含它们的药物组合物
- Patent Title: 1,3,5-triazine-2,4,6-triamine compound or pharmaceutical acceptable salt thereof, and pharmaceutical composition comprising the same
- Patent Title (中): 1,3,5-三嗪-2,4,6-三胺化合物或其药学上可接受的盐，以及包含它们的药物组合物
-
Application No.: US12674886Application Date: 2008-08-28
-
Publication No.: US08722674B2Publication Date: 2014-05-13
- Inventor: Hyae Gyeong Cheon , Kwang-Rok Kim , Sang Dal Rhee , Won Hoon Jung , Jong-Cheol Lee , Sung Wuk Kim , Sung Soo Jun
- Applicant: Hyae Gyeong Cheon , Kwang-Rok Kim , Sang Dal Rhee , Won Hoon Jung , Jong-Cheol Lee , Sung Wuk Kim , Sung Soo Jun
- Applicant Address: KR Daejeon
- Assignee: Hanall Biopharma Co., Ltd.
- Current Assignee: Hanall Biopharma Co., Ltd.
- Current Assignee Address: KR Daejeon
- Agency: Swanson & Bratschun, LLC
- Priority: KR10-2007-0088115 20070831
- International Application: PCT/KR2008/005062 WO 20080828
- International Announcement: WO2009/028891 WO 20090305
- Main IPC: A61K31/53
- IPC: A61K31/53 ; C07D251/54 ; C07D403/00 ; C07D251/70
Abstract:
Disclosed herein are a 1,3,5-triazine-2,4,6-triamine compound or a pharmaceutically acceptable salt thereof, a preparation method thereof, and a composition for preventing or treating metabolic syndromes, diabetes, or cancers with deletion of P53 gene, which comprises the same.
Public/Granted literature
Information query
